Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Amphastar Pharmaceuticals, Inc. (AMPH)

$25.14 -3.46% NASDAQ: AMPH · 15-min delayed
  • RANCHO CUCAMONGA, California
  • Public · NASDAQ: AMPH
  • 1,976 employees
$825.4MMarket cap
$719.9MRevenue · FY2025
$98.1MNet income
1,976Employees
AMPHNASDAQ
2014IPO

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$719.9M
Net income
$98.1M
Total assets
$1.6B
Market cap
$825.4M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: AMPH
$25.14 -3.46%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$16.87 $29.40

52-week range

Market cap
$825.4M
Shares outstanding
32.8M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Jun 25, 2014

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price

  • Profitable — net income of $98.1M in FY2025.
  • Trading 14% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Amphastar Pharmaceuticals, Inc..

Write a review
Newsroom

News about Amphastar Pharmaceuticals, Inc.

News & sentiment via Polygon.io

FAQ

Amphastar Pharmaceuticals, Inc.: frequently asked questions

Is Amphastar Pharmaceuticals, Inc. an American company?

Amphastar Pharmaceuticals, Inc. is a US-based company headquartered in Rancho Cucamonga, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Amphastar Pharmaceuticals, Inc. headquartered?

Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California, United States.

Is Amphastar Pharmaceuticals, Inc. publicly traded?

Yes — Amphastar Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol AMPH on the NASDAQ.

What does Amphastar Pharmaceuticals, Inc. do?

Amphastar Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →